Women’s Health Week gets NYSE backing

A women’s health conference in Manhattan just got a partner normally associated with initial public offerings and opening bells: the New York Stock Exchange signed on as the official exchange partner for Women’s Health Week USA, which will run on May 13 and May 14 at the New York Academy of Medicine. (femtechworld.co.uk) That partnership is not just a logo placement. The event says it will appear in the New York Stock Exchange Market Update on May 13, a segment it says reaches about 200 million viewers through outlets including Yahoo Finance and the Financial Times. (femtechworld.co.uk) The conference will also get a week on the North Star billboard in Times Square, and the exchange says it will record live and taped interviews with conference leaders and keynote speakers for distribution on New York Stock Exchange media channels. (femtechworld.co.uk) Women’s Health Week USA is built less like a medical convention and more like a deal room. Its organizers say the 2026 event is set for 600-plus attendees, 60-plus speakers, and 30-plus sponsors, with founders, investors, payers, providers, corporate executives, and policymakers all in the same building. (womenshealthweek.com) The guest list shows why the stock-exchange tie-in fits. The agenda names executives from Maven Clinic, Carrot Fertility, Kindbody, Uber Health, the Food and Drug Administration, the National Institutes of Health, the World Health Organization, and the New York Stock Exchange itself. (womenshealthweek.com) The program is also aimed at companies that want money and distribution, not just applause. The event brochure says there will be 15 startup pitches across two tracks, one for medical devices and therapeutics and one for consumer and technology products, plus curated one-to-one matchmaking for more than 700 senior delegates. (womenshealthweek.com) That matters because women’s health has often been treated as a niche category inside healthcare, even though it covers giant markets like fertility, menopause, maternal care, contraception, diagnostics, and chronic conditions that present differently in women. The conference website now frames the sector as moving from “growth to scale,” with acquisitions, partnerships, and larger funding rounds replacing the earlier startup-only phase. (womenshealthweek.com) The organizers are explicit about the money story. Their site says United States women’s health deals have raised hundreds of millions of dollars since January 2025, with Series A and Series B rounds above $20 million helping push the sector toward larger exits. (womenshealthweek.com) The exchange’s brand gives that story a different audience. On its own website, the New York Stock Exchange describes itself as a capital-markets platform built to help companies raise capital, which is exactly the language later-stage women’s health companies need as they move from pilot programs to national distribution and, eventually, public markets. (nyse.com) This conference is separate from the federal government’s National Women’s Health Week, which the United States Department of Health and Human Services observes each May as a public-health awareness campaign. Women’s Health Week USA is a private industry summit using nearly the same calendar window to bring finance, policy, and healthcare buyers into one forum. (orwh.od.nih.gov, womenshealthweek.com) So the real news is not that a conference found a sponsor. It is that one of the best-known institutions in American finance is lending its stage, screens, and media machine to a women’s health event that is openly pitching itself as a marketplace for scale. (femtechworld.co.uk, womenshealthweek.com)